Diagnosoft Company

Diagnosoft“ provides innovative healthcare software analysis tools focused on supporting the cardiolvascular field. The company is well known for developing HARP“, the first FDA 510k-cleared software for tagged MR images, which is a component of the company's complete end-to-end solution for the analysis and quantification of cardiac magnetic resonance images. Diagnosoft is also developing transformative clinical analytics solutions for healthcare. Our FUSION product uses a unique clinical insight and intelligence engine to aggregate patient data and generate comprehensive, real-time views of patient health status. This unprecedented software compiles and analyzes data directly from EMRs and other sources, and gives healthcare providers an easy-to-read, meaningful view of the patient's status right at the point of care.
Technology: Clinical Data Management Platforms, P4 Medicine
Industry: Clinical Data Management, Health Care, Health Diagnostics, Software, Wellness
Headquarters: Research Triangle, East Coast, Southern US
Founded Date: 01.01.2002
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 1
Total Funding: $4M
Estimated Revenue: $1M to $10M
Last Funding Type: Series B

Visit Website
https://twitter.com/diagnosoft
Register and Claim Ownership